Chuq Centre Hospitalier Universitaire de Quebec

Québec G1R 2J6

0 studies enrolling now · 1 studies all time

What they study most

Malignant Melanoma

Studies at this site

• Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma — NO_LONGER_AVAILABLE